Huifeng Hao Selected Research

Hypertension (High Blood Pressure)

1/2020

The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huifeng Hao Research Topics

Disease

8	Neoplasms (Cancer) 06/2023 - 06/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 06/2020
2	Carcinogenesis 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 11/2022 - 06/2020
2	Inflammation (Inflammations) 12/2020 - 01/2020
2	Hyperplasia 01/2020 - 01/2018
2	Neointima 01/2020 - 01/2018
1	Migraine Disorders (Migraine) 10/2023
1	Adenocarcinoma of Lung 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Atherosclerosis 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Ischemia 01/2019
1	Heart Failure 01/2019
1	Reperfusion Injury 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Vascular Remodeling 01/2018
1	Myocardial Infarction 03/2017
1	Infarction (Infarctions) 03/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
3	LipidsIBA 01/2023 - 03/2017
2	Gefitinib (Iressa)FDA Link 06/2023 - 06/2020
2	Therapeutic UsesIBA 01/2023 - 01/2020
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2023
1	hepatoma-derived growth factorIBA 06/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	IronIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	AngiopoietinsIBA 11/2022
1	bu-fei decoctionIBA 11/2022
1	angiogeninIBA 11/2022
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2022
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2022
1	CateninsIBA 01/2022
1	BerberineIBA 01/2022
1	tenuifolin diterpeneIBA 12/2020
1	polygalacic acidIBA 12/2020
1	tenuigeninIBA 12/2020
1	polygalasaponin XXXIIIBA 12/2020
1	AntioxidantsIBA 12/2020
1	tau Proteins (tau Protein)IBA 12/2020
1	Cholinergic Agents (Cholinergics)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 06/2020
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 06/2020
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	ColforsinIBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Cyclooxygenase 1IBA 01/2019
1	EP4 Subtype Prostaglandin E ReceptorsIBA 01/2019
1	Prostaglandin-E SynthasesIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	Cardiovascular AgentsIBA 03/2017
1	Chemokine CXCL12IBA 03/2017

Therapy/Procedure

4	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2022 - 06/2019
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2023
2	Therapeutics 11/2022 - 01/2020
1	Intravenous Injections 11/2022
1	Oral Administration 03/2020
1	Percutaneous Coronary Intervention 01/2020